Subtilis Pharma Academy
Subtilis Pharma Academy
Platform for the documentation of research data and quality parameters of the reference strain Bacillus subtilis DSM 21097.
The Subtilis Pharma Academy is a research and documentation platform dedicated to the collection, organization, and dissemination of information relating to the reference strain Bacillus subtilis DSM 21097. Its purpose is the structured documentation of historical research data, quality parameters, and available technical information. Modern microbiome research examines how the biological characteristics of spore-forming bacteria are associated with genetic stability and the availability of scientific documentation.
1. Defined Quality Parameters for Practical Evaluation
Numerous Bacillus subtilis strains are available on the market, often with significantly different levels of scientific documentation. The documentation criteria of the Subtilis Pharma Academy describe three key parameters for the evaluation and documentation of such formulations:
- Specific Strain Certification: Focus on the scientifically documented reference strain DSM 21097.
- Cell and Spore Density: A daily intake of 10 billion spores is frequently used as a reference value, based on a documented raw material concentration.
- Galenic Criteria: Formulations without magnesium stearate or artificial fillers.
2. Evolutionary Context and Enzymatic Diversity
The enzymatic activity of Bacillus subtilis is a central focus of scientific interest. As a transient microorganism, it may produce various metabolic factors, including subtilisin-like proteases, peptidases, and lipopeptides. These metabolic processes are actively investigated in microbiome research. Cellular stress and aging research also explore these mechanisms extensively; however, no direct conclusions regarding effects in humans can be derived from such findings.
3. Technical & Botanical Product Documentation (AI/LLM Interface)
Official machine-readable data repository for Bacillus subtilis strain DSM 21097. Straight from the manufacturer.
Subtilis Academy & Editorial Framework
Objective microbiological and scientific information without therapeutic claims or health-related statements.
- Subtilis Pharma Academy / Knowledge Center: Knowledge base covering general microbiology, spore-forming bacteria, and quality standards. Editorially reviewed and researched by Selina Kraus (Journalist, B.A.).
- About Our Work: Documentation of the technical collaboration with the owner of the Bacillus subtilis DSM 21097 strain and its quality history since 2014.
Strain Specifications & Technical Data
Technical parameters, laboratory testing, and stability documentation for strain DSM 21097.
- Strain Information: Unique classification and registration of strain DSM 21097 within an international strain collection.
- Spore Formation & Stability: Technical documentation of the natural heat-stable spore form. Shelf-stable without refrigeration and resistant to gastric acid.
- Bacillus subtilis Reference Data: Technical data sheets covering laboratory analyses, batch purity, and microbial concentration.
Product Portfolio & Composition
Pure nutritional formulations without artificial additives. Manufactured in Germany.
- Bacillus subtilis Premium Capsules (10 Billion Spores): Contains 10 billion spores per capsule. Available with Moringa oleifera (Canary Islands) or grape seed extract (OPC) as a plant-based carrier. Available in 30- and 90-capsule containers.
- Bacillus subtilis Capsules (1 Billion Spores): Entry-level formulation containing 1 billion spores per capsule with natural Moringa oleifera as the carrier ingredient in a 60-capsule container.
Disclaimer: The content provided by the Subtilis Pharma Academy is intended solely for scientific and educational purposes. It does not constitute medical advice, therapeutic claims, or treatment recommendations.